Toviaz (U.S. Pharmaceuticals)
Welcome to the PulseAid listing for the Toviaz drug offered from U.S. Pharmaceuticals. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | U.S. Pharmaceuticals |
NON-PROPRIETARY NAME: | fesoterodine fumarate |
SUBSTANCE NAME: | FESOTERODINE FUMARATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, FILM COATED, EXTENDED RELEASE |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2008-10-31 |
END MARKETING DATE: | 0000-00-00 |
Toviaz HUMAN PRESCRIPTION DRUG Details:
Item Description | Toviaz from U.S. Pharmaceuticals |
LABELER NAME: | U.S. Pharmaceuticals |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 8(mg/1) |
START MARKETING DATE: | 2008-10-31 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 63539-183_47f19c39-9fd2-4471-9d91-08da92d4fb68 |
PRODUCT NDC: | 63539-183 |
APPLICATION NUMBER: | NDA022030 |
Other FESOTERODINE FUMARATE Pharmaceutical Manufacturers / Labelers: